Cue Biopharma (CUE) Intangibles (2017 - 2018)

Cue Biopharma's (CUE) quarterly Intangibles came in at $175000.0 in Q3 2018, little changed quarter-over-quarter from $175000.0 in Q2 2018.

Cue Biopharma (CUE) Intangibles (2017 - 2018) Analysis & Trends

Cue Biopharma has disclosed Intangibles across 2 years of filings, most recently posting $175000.0 for Q3 2018.

Intangibles for Q3 2018 came in at $175000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $175000.0 (changed N/A YoY), and the FY2017 annual result was $175000.0, changed N/A from the prior year.
Intangibles came in at $175000.0 for Q3 2018 at Cue Biopharma, roughly flat from $175000.0 in the prior quarter.
In the past five years, Intangibles ranged from a high of $175000.0 in Q4 2017 to a low of $175000.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	4.41 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	30.30 Mn
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	418.50 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	7.73 Mn
10	Cue Biopharma	581.16 Mn	553.47 Mn	-	-

Download Data